Menu
Open Access
Issue
Ann Toxicol Anal
Volume 25, Number 2, 2013
Page(s) 75 - 78
DOI https://doi.org/10.1051/ata/2013042
Published online 27 September 2013
  1. Lysanxia®. Résumé Caractéristiques Produit. Laboratoires Lynapharm. AMM 1988. [Google Scholar]
  2. Baselt RC. Disposition of toxic drugs and chemicals in man. Ninth Edition. Biomedical Publications, Seal Beach. 2011, 1877 p. [Google Scholar]
  3. Roussel O, Suply B, Perrin M. Intoxication au méprobamate : à propos de deux cas. Ann Toxicol Anal. 2008; 20(2) : 89–95. [CrossRef] [EDP Sciences] [Google Scholar]
  4. Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1000 drugs and others xenobiotics. Crit Care. 2012; 16(4) : 1–146. [Google Scholar]
  5. Altamura AC, Moliterno D, Paletta S, Maffini M, Mauri MC, Bareggi S. Understanding the pharmacokinetics of anxiolytic drugs. Expert Opin Drug Metab Toxicol. 2013; 9(4) : 423–440. [CrossRef] [PubMed] [Google Scholar]
  6. La revue Prescrire. Guide des interactions médicamenteuses 2013. 2012; 32(350) : 174–175. [Google Scholar]
  7. Di-antalvic®. Résumé Caractéristiques Produit. Laboratoires Sanofi-Aventis France. AMM 2001. [Google Scholar]
  8. Young RJ. Dextropropoxyphene overdosage. Pharmacological considerations and clinical management. Drugs. 1983; 26(1) : 70–79. [Google Scholar]